University of Regensburg

uni-regensburg.de

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

69

Active

6

Phase 3

5

Total enrollment

7,187

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Depression9
  • Chronic Tinnitus9
  • Tinnitus6
  • Postoperative Residual Curarization2
  • Colorectal Cancer Metastatic2
  • Schizophrenia2
  • Hepatocellular Carcinoma2
  • Peritoneal Carcinomatosis2

Frequently asked questions about University of Regensburg

How many clinical trials does University of Regensburg have on ClinicalTrials.gov?
University of Regensburg is listed as the lead sponsor on 69 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
How many of University of Regensburg's trials are in Phase 3?
5 of University of Regensburg's trials are in Phase 3.
What therapeutic areas does University of Regensburg focus on?
University of Regensburg's most-studied conditions on ClinicalTrials.gov are Depression, Chronic Tinnitus, Tinnitus, Postoperative Residual Curarization, Colorectal Cancer Metastatic.